Compounds > malondialdehyde
Page last updated: 2024-08-21

malondialdehyde and Cochlear Hearing Loss

malondialdehyde has been researched along with Cochlear Hearing Loss in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, B; Xiao, H1
Anokhina, EA; Zolotova, TV1
He, Q; Lai, H; Wang, J; Xiong, M1
Husain, K; Kelly, TC; Rybak, LP; Whitworth, CA1
Husain, K; Rybak, LP; Scott, B; Whitworth, C1
Husain, K; Rybak, LP; Somani, SM; Whitworth, C1

Other Studies

6 other study(ies) available for malondialdehyde and Cochlear Hearing Loss

ArticleYear
Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
    Biochemical and biophysical research communications, 2014, Jun-13, Volume: 448, Issue:4

    Topics: Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cisplatin; Cochlea; Disease Models, Animal; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Outer; Hearing Loss, Sensorineural; Humans; Male; Malondialdehyde; Microtubule-Associated Proteins; Oxidative Stress; Rats; Rats, Wistar; Sirolimus

2014
[Changes of oxidative and antioxidative properties of blood under the action of perftoran in patients with acute sensorineural loss of hearing].
    Vestnik otorinolaringologii, 2010, Issue:4

    Topics: Adolescent; Adult; Blood Substitutes; Catalase; Female; Fluorocarbons; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Infusions, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Treatment Outcome; Young Adult

2010
Astragalosides reduce cisplatin ototoxicity in guinea pigs.
    ORL; journal for oto-rhino-laryngology and its related specialties, 2011, Volume: 73, Issue:3

    Topics: Animals; Antineoplastic Agents; Antioxidants; Astragalus Plant; Auditory Threshold; Cisplatin; Disease Models, Animal; Drug Interactions; Drugs, Chinese Herbal; Guinea Pigs; Hair Cells, Auditory, Outer; Hearing Loss, Sensorineural; Malondialdehyde; Nitric Oxide; Oxidative Stress

2011
Aminoguanidine reduces cisplatin ototoxicity.
    Hearing research, 2003, Volume: 186, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Audiometry, Evoked Response; Auditory Threshold; Cisplatin; Enzyme Inhibitors; Evoked Potentials, Auditory, Brain Stem; Follow-Up Studies; Guanidines; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ of Corti; Rats; Rats, Wistar

2003
Time response of carboplatin-induced hearing loss in rat.
    Hearing research, 2004, Volume: 191, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Case-Control Studies; Cochlea; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Glutathione; Glutathione Disulfide; Hearing Loss, Sensorineural; Humans; Male; Malondialdehyde; Models, Animal; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase

2004
Partial protection by lipoic acid against carboplantin-induced ototoxicity in rats.
    Biomedical and environmental sciences : BES, 2005, Volume: 18, Issue:3

    Topics: Animals; Antioxidants; Auditory Threshold; Carboplatin; Catalase; Cochlea; Evoked Potentials, Auditory, Brain Stem; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Hearing Loss, Sensorineural; Lipid Peroxidation; Male; Malondialdehyde; Protective Agents; Rats; Rats, Wistar; Superoxide Dismutase; Thioctic Acid

2005